Serum and fecal zonulin as a biomarker of increased intestinal epithelial permeability in patients with renal insufficiency

Abstract

BACKGROUND: Determination of zonulin level in body fluids is one of the widely used clinical methods for diagnosing the leaky gut syndrome. Meanwhile, a decrease in the glomerular filtration rate can potentially affect the content of zonulin in patients with impaired renal function.

AIM: to evaluate the content of serum and fecal zonulin in subjects at different stages of chronic kidney disease.

MATERIALS AND METHODS: The cross-sectional study included 3 groups of patients: 1) 155 patients with end-stage renal disease receiving hemodialysis treatment; 2) 30 patients with chronic kidney disease C3a-5 (glomerular filtration rate <60 ml/min/1.73 m²); 3) 20 relatively healthy individuals with glomerular filtration rate >60 ml/min/1.73 m². The groups were comparable in gender, age, body mass index, smoking status and etiological structure of chronic kidney disease. The concentration of zonulin in blood serum and feces was assessed by using commercially available ELISA kit.

RESULTS: There were no significant differences in serum zonulin between groups. There was a significant direct correlation of serum zonulin with age, creatinine, C-reactive protein and inverse with glomerular filtration rate in patients at predialysis stages of chronic kidney disease. At the same time, in hemodialysis patients serum zonulin did not depend on any of the defined clinical and demographic indicators.It was also found that the concentration of fecal zonulin significantly increased concurrently with an advance of renal insufficiency and reached maximum values in patients with end-stage renal disease. Meanwhile, the correlation analysis did not reveal association between fecal zonulin and kidney function parameters in individuals with mild and moderate chronic kidney disease. Only the hemodialysis group observed a significant direct correlation of fecal zonulin with C-reactive protein.

CONCLUSION: Evaluation of fecal, but not serum zonulin level is preferable to use as a biomarker of increased intestinal epithelial permeability in patients with impaired renal function, since its concentration in the blood is likely to be significantly affected by reduced glomerular filtration rate.

Keywords

chronic kidney disease / glomerular filtration rate / hemodialysis / intestinal permeability / leaky gut syndrome / zonulin

References

[1] Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68(8):1516–1526. DOI: 10.1136/gutjnl-2019-318427

[2] Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans // Gut. 2019. Vol. 68, No. 8. P. 1516–1526. DOI: 10.1136/gutjnl-2019-318427

[3] Pyatchenkov MO, Salikova SP, Shcherbakov EV, Vlasov AA. The state of the microbial-tissue complex of the intestine in patients with chronic kidney disease. Bulletin of the Russian Military Medical Academy. 2023;25(1):155–164. DOI: 10.17816/brmma124822

[4] Пятченков М.О., Саликова С.П., Щербаков Е.В., Власов А.А. Состояние микробно-тканевого комплекса кишечника у больных хронической болезнью почек // Вестник Российской военно-медицинской академии. 2023. Т. 25, № 1. C. 155–164. DOI: 10.17816/brmma124822

[5] Tkachenko EI, Grinevich VB, Gubonina IV, et al. Diseases as a result of violations of the symbiotic relationship of the host organism with the microbiota and pathogens. Bulletin of the Russian Military Medical Academy. 2021;23(2):243–252. DOI: 10.17816/brmma58117.1

[6] Ткаченко Е.И., Гриневич В.Б., Губонина И.В., и др. Болезни как следствие нарушений симбиотических взаимоотношений организма хозяина с микробиотой и патогенами // Вестник Российской военно-медицинской академии. 2021. Т. 23, № 2. С. 243–252. DOI: 10.17816/brmma58117

[7] Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res. 2020;9: F1000 Faculty Rev-69. DOI: 10.12688/f1000research.20510.1

[8] Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases // F1000Res. 2020. Vol. 9. F1000 Faculty Rev-69. DOI: 10.12688/f1000research.20510.1

[9] Pyatchenkov MO, Vlasov AA, Shcherbakov EV, et al. Features of assessing the permeability of the intestinal barrier in chronic kidney disease. Experimental and Clinical Gastroenterology. 2022;(11):46–59. DOI: 10.31146/1682-8658-ecg-207-11-46-59

[10] Пятченков М.О., Власов А.А., Щербаков Е.В., и др. Особенности оценки проницаемости кишечного барьера при хронической болезни почек // Экспериментальная и клиническая гастроэнтерология. 2022. № 11. С. 46–59. DOI: 10.31146/1682-8658-ecg-207-11-46-59

[11] Fasano A. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Ann NY Acad Sci. 2000;915:214–222. DOI: 10.1111/j.1749-6632.2000.tb05244.x

[12] Fasano A. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin // Ann. NY Acad. Sci. 2000. Vol. 915. P. 214–222. DOI: 10.1111/j.1749-6632.2000.tb05244.x

[13] Markov A, Aschenbach J, Amasheh S. The epithelial barrier and beyond: claudins as amplifiers of physiological organ functions. IUBMB Life. 2017;69(5):290–296. DOI: 10.1002/iub.1622

[14] Markov A., Aschenbach J., Amasheh S. The epithelial barrier and beyond: claudins as amplifiers of physiological organ functions // IUBMB Life. 2017. Vol. 69, No. 5. P. 290–296. DOI: 10.1002/iub.1622

[15] Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151–175. DOI: 10.1152/physrev.00003.2008

[16] Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer // Physiol. Rev. 2011. Vol. 91, No. 1. P. 151–175. DOI: 10.1152/physrev.00003.2008

[17] Yu J, Shen Y, Zhou N. Advances in the role and mechanism of zonulin pathway in kidney diseases. Int Urol Nephrol. 2021;53(10): 2081–2088. DOI: 10.1007/s11255-020-02756-9

[18] Yu J., Shen Y., Zhou N. Advances in the role and mechanism of zonulin pathway in kidney diseases // Int. Urol. Nephrol. 2021. Vol. 53, No. 10. P. 2081–2088. DOI: 10.1007/s11255-020-02756-9

[19] El Asmar R, Panigrahi P, Bamford P, et al. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology. 2002;123(5): 1607–1615. DOI: 10.1053/gast.2002.36578

[20] El Asmar R., Panigrahi P., Bamford P., et al. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure // Gastroenterology. 2002. Vol. 123, No. 5. P. 1607–1615. DOI: 10.1053/gast.2002.36578

[21] Pyatchenkov MO, Markov AG, Rumyantsev ASh. Structural and functional disorders of the intestinal barrier and chronic kidney disease. Literature review. Part I. Nephrology. 2022;26(1):10–26. DOI: 10.36485/1561-6274-2022-26-1-10-26

[22] Пятченков М.О., Марков А.Г., Румянцев А.Ш. Структурно-функциональные нарушения кишечного барьера и хроническая болезнь почек. Обзор литературы. Ч. I // Нефрология. 2022. Т. 26, № 1. С. 10–26. DOI: 10.36485/1561-6274-2022-26-1-10-26

[23] Pyatchenkov MO, Rumyantsev ASh, Shcherbakov EV, Markov AG. Structural and functional disorders of the intestinal barrier and chronic kidney disease. Literature review. Part II. Nephrology. 2022;26(2):46–64. DOI: 10.36485/1561-6274-2022-26-2-46-64

[24] Пятченков М.О., Румянцев А.Ш., Щербаков Е.В., Марков А.Г. Структурно-функциональные нарушения кишечного барьера и хроническая болезнь почек. Обзор литературы. Ч. II // Нефрология. 2022. Т. 26, № 2. С. 46–64. DOI: 10.36485/1561-6274-2022-26-2-46-64

[25] Ficek J, Wyskida K, Ficek R, et al. Relationship between plasma levels of zonulin, bacterial lipopolysaccharides, D-lactate and markers of inflammation in haemodialysis patients. Int Urol Nephrol. 2017;49(4):717–725. DOI: 10.1007/s11255-016-1495-5

[26] Ficek J., Wyskida K., Ficek R., et al. Relationship between plasma levels of zonulin, bacterial lipopolysaccharides, D-lactate and markers of inflammation in haemodialysis patients // Int. Urol. Nephrol. 2017. Vol. 49, No. 4. P. 717–725. DOI: 10.1007/s11255-016-1495-5

[27] Carpes L, Nicoletto B, Canani L, et al. Could serum zonulin be an intestinal permeability marker in diabetes kidney disease? PLoS One. 2021;16(6):e0253501. DOI: 10.1371/journal.pone.0253501

[28] Carpes L., Nicoletto B., Canani L., et al. Could serum zonulin be an intestinal permeability marker in diabetes kidney disease? // PLoS One. 2021. Vol. 16, No. 6. P. e0253501. DOI: 10.1371/journal.pone.0253501

[29] Sirin F, Korkmaz H, Eroglu I, et al. Serum zonulin levels in type 2 diabetes patients with diabetic kidney disease. Endokrynol Pol. 2021;72(5):545–549. DOI: 10.5603/EP.a2021.0056

[30] Sirin F., Korkmaz H., Eroglu I., et al. Serum zonulin levels in type 2 diabetes patients with diabetic kidney disease // Endokrynol. Pol. 2021. Vol. 72, No. 5. P. 545–549. DOI: 10.5603/EP.a2021.0056

[31] Hasslacher C, Kulozik F, Platten I, et al. Serum zonulin as parameter of intestinal permeability in longstanding type 2 diabetes: correlations with metabolism parameter and renal function. J Diabetes Metab Disord Control. 2018;5(2):58–62. DOI: 10.15406/jdmdc.2018.05.00138

[32] Hasslacher C., Kulozik F., Platten I., et al. Serum zonulin as parameter of intestinal permeability in longstanding type 2 diabetes: correlations with metabolism parameter and renal function // J. Diabetes Metab. Disord. Control. 2018. Vol. 5, No. 2. P. 58–62. DOI: 10.15406/jdmdc.2018.05.00138

[33] Lukaszyk E, Lukaszyk M, Koc-Zorawska E, et al. Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease. Int Urol Nephrol. 2018;50(1):121–125. DOI: 10.1007/s11255-017-1741-5

[34] Lukaszyk E., Lukaszyk M., Koc-Zorawska E., et al. Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease // Int. Urol. Nephrol. 2018. Vol. 50, No. 1. P. 121–125. DOI: 10.1007/s11255-017-1741-5

[35] Dschietzig T, Boschann F, Ruppert J, et al. Plasma Zonulin and its Association with Kidney Function, Severity of Heart Failure, and Metabolic Inflammation. Clin Lab. 2016;62(12):2443–2447. DOI: 10.7754/Clin.Lab.2016.160512

[36] Dschietzig T., Boschann F., Ruppert J., et al. Plasma Zonulin and its Association with Kidney Function, Severity of Heart Failure, and Metabolic Inflammation // Clin. Lab. 2016. Vol. 62, No. 12. P. 2443–2447. DOI: 10.7754/Clin.Lab.2016.160512

[37] Malyszko J, Koc-Zorawska E, Levin-Iaina N, Malyszko J. Zonulin, iron status, and anemia in kidney transplant recipients: are they related? Transplant Proc. 2014;46(8):2644–2646. DOI: 10.1016/j.transproceed.2014.09.018

[38] Malyszko J., Koc-Zorawska E., Levin-Iaina N., Malyszko J. Zonulin, iron status, and anemia in kidney transplant recipients: are they related? // Transplant. Proc. 2014. Vol. 46, No. 8. P. 2644–2646. DOI: 10.1016/j.transproceed.2014.09.018

[39] Al-Obaide MAI, Singh R, Datta P, et al. Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD. J Clin Med. 2017;6(9):86. DOI: 10.3390/jcm6090086

[40] Al-Obaide M.A.I., Singh R., Datta P., et al. Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD // J. Clin. Med. 2017. Vol. 6, No. 9. P. 86. DOI: 10.3390/jcm6090086

[41] Pereira NBF, Ramos CI, de Andrade LS, et al. Influence of bowel habits on gut-derived toxins in peritoneal dialysis patients. J Nephrol. 2020;33(5):1049–1057. DOI: 10.1007/s40620-020-00819-9

[42] Pereira N.B.F., Ramos C.I., de Andrade L.S., et al. Influence of bowel habits on gut-derived toxins in peritoneal dialysis patients // J. Nephrol. 2020. Vol. 33, No. 5. P. 1049–1057. DOI: 10.1007/s40620-020-00819-9

[43] Li Q, Yuan X, Shi S, et al. Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis. Clin Kidney J. 2022;16(1):184–191. DOI: 10.1093/ckj/sfac214

[44] Li Q., Yuan X., Shi S., et al. Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis // Clin. Kidney J. 2022. Vol. 16, No. 1. P. 184–191. DOI: 10.1093/ckj/sfac214

[45] Zhou N, Shen Y, Fan L, et al. The Characteristics of Intestinal-Barrier Damage in Rats With IgA Nephropathy. Am J Med Sci. 2020;359(3):168–176. DOI: 10.1016/j.amjms.2019.11.011

[46] Zhou N., Shen Y., Fan L., et al. The Characteristics of Intestinal-Barrier Damage in Rats With IgA Nephropathy // Am. J. Med. Sci. 2020. Vol. 359, No. 3. P. 168–176. DOI: 10.1016/j.amjms.2019.11.011

[47] Trachtman H, Gipson D, Lemley K, et al. Plasma Zonulin Levels in Childhood Nephrotic Syndrome. Front Pediatr. 2019;7:197. DOI: 10.3389/fped.2019.00197

[48] Trachtman H., Gipson D., Lemley K., et al. Plasma Zonulin Levels in Childhood Nephrotic Syndrome // Front. Pediatr. 2019. Vol. 7. P. 197. DOI: 10.3389/fped.2019.00197

[49] Madhusudhan T, Wang H, Straub BK, et al. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood. 2012;119(3):874–883. DOI: 10.1182/blood-2011-07-365973

[50] Madhusudhan T., Wang H., Straub B.K., et al. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes // Blood. 2012. Vol. 119, No. 3. P. 874–883. DOI: 10.1182/blood-2011-07-365973

[51] Scheffler L, Crane A, Heyne H, et al. Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family. Front Endocrinol (Lausanne). 2018;9:22. DOI: 10.3389/fendo.2018.00022

[52] Scheffler L., Crane A., Heyne H., et al. Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family // Front. Endocrinol (Lausanne). 2018. Vol. 9. P. 22. DOI: 10.3389/fendo.2018.00022

[53] Vojdani A, Vojdani E, Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol. 2017;23(31):5669–5679. DOI: 10.3748/wjg.v23.i31.5669

[54] Vojdani A., Vojdani E., Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies // World J. Gastroenterol. 2017. Vol. 23, No. 31. P. 5669–5679. DOI: 10.3748/wjg.v23.i31.5669

RIGHTS & PERMISSIONS

Eco-Vector